Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma

Autor: J. R. Joubert, Macé M. Schuurmans, Elvis M Irusen, Haylene Nell, Daphne C Richter
Jazyk: angličtina
Rok vydání: 2008
Předmět:
Spirometry
Male
medicine.medical_specialty
Vital capacity
diagnosis
Vital Capacity
International Journal of Chronic Obstructive Pulmonary Disease
Sensitivity and Specificity
Severity of Illness Index
Pulmonary function testing
Diagnosis
Differential

FEV1/FVC ratio
Pulmonary Disease
Chronic Obstructive

Predictive Value of Tests
Internal medicine
Forced Expiratory Volume
Administration
Inhalation

medicine
obstructive lung disease
Humans
Albuterol
Prospective Studies
Asthma
Original Research
lcsh:RC705-779
COPD
medicine.diagnostic_test
business.industry
lcsh:Diseases of the respiratory system
General Medicine
respiratory system
Middle Aged
medicine.disease
post-bronchodilator pulmonary function test
Obstructive lung disease
respiratory tract diseases
Bronchodilator Agents
Respiratory Function Tests
Predictive value of tests
Cardiology
Physical therapy
Female
business
Zdroj: International Journal of Chronic Obstructive Pulmonary Disease
Scopus-Elsevier
International Journal of COPD, Vol 2008, Iss Issue 4, Pp 693-699 (2008)
ISSN: 1178-2005
1176-9106
Popis: Daphne C Richter1, James R Joubert1, Haylene Nell1, Mace M Schuurmans2, Elvis M Irusen21Tiervlei Trial Centre, Karl Bremer Hospital, Bellville, RSA; 2Respiratory Research Unit, Department of Internal Medicine, Faculty of Health Sciences, University of Stellenbosch, RSAObjective: The GOLD guidelines suggest that the presence of a post-bronchodilator forced expiratory volume in one second (FEV1) 80% of the predicted value in combination with a FEV1/forced vital capacity (FVC)< 70% confirms the diagnosis of COPD. Limited data exist regarding the accuracy of these criteria to distinguish between COPD and asthma. The aim of this study therefore was to investigate the diagnostic value of post-bronchodilator lung function parameters in obstructive lung disease.Methods: The pulmonary function tests of 43 (22 = COPD, 21 = asthma) patients with similar baseline characteristics were evaluated (baseline FEV1 were 55.7% + 7.6%, and 59.3% + 8.4% predicted for COPD and asthma, respectively). Bronchodilator responsiveness (BDR) was calculated according to three recognized pulmonary function test criteria.Results: The first criteria, post-bronchodilator FEV1< 80% of the predicted value in combination with a post-bronchodilator FEV1/FVC ratio of 
Databáze: OpenAIRE